We are live on
!
Find out more
AA
Antipodean Advisors Portfolio holdings
AUM
$19.5M
1-Year Est. Return
6.21%
This Fund
S&P 500
This Quarter
Est. Return
-23.08%
1 Year Est. Return
-6.21%
3 Year Est. Return
-67.79%
5 Year Est. Return
+67.26%
10 Year Est. Return
+1,117.22%
AUM
$244M
AUM Growth
-$110M
(-31%)
Cap. Flow
-$34.9M
Cap. Flow
% of AUM
-14.31%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
2
Closed
3
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clarivate
CLVT
|
+$17.4M |
| 2 |
Invivyd
IVVD
|
+$8.03M |
| 3 |
ICICI Bank
IBN
|
+$7.55M |
| 4 |
NKLA
Nikola Corporation Common Stock
NKLA
|
+$1.07M |
| 5 |
Atara Biotherapeutics
ATRA
|
+$842K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 70.68% |
| 2 | Communication Services | 17.33% |
| 3 | Healthcare | 8.36% |
| 4 | Technology | 3.62% |
| 5 | Financials | 0% |
Similar funds
CVSCT
DOS
SIC
LUGPI
RCP
IVM
CCFM
VNB
Antipodean Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Antipodean Advisors held 9 positions worth $244M, down 31% from $353M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Antipodean Advisors withdrew a net $34.9M in Q4 2021, closing 3 positions and reducing 2 holdings. Its most notable exit was Invivyd, an estimated $8.03M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 71% of assets, up from 66% a quarter earlier, followed by Communication Services and Healthcare.
- Antipodean Advisors's biggest Q4 2021 reduction was Clarivate, cutting an estimated $17.4M.
- Antipodean Advisors fully exited Invivyd in Q4 2021, selling an estimated $8.03M.
- Antipodean Advisors's ten largest holdings make up 100% of its $244M portfolio in Q4 2021.
- Antipodean Advisors opened 0 new positions and closed 3 in Q4 2021.
- Antipodean Advisors's portfolio value fell 31% quarter-over-quarter to $244M.
Based on Antipodean Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.